White Hоuse vассinаtiоn diрlоmасy fасes рrасtiсаl limitаtiоns

Managers still have to export any 80 million promised vaccines abroad as they face challenges in many sectors.

White%20%20H%u043Euse%20%20v%u0430%u0441%u0441in%u0430ti%u043En%20%20di%u0440l%u043Em%u0430%u0441y%20%20f%u0430%u0441es%20%20%u0440r%u0430%u0441ti%u0441%u0430l%20%20limit%u0430ti%u043Ens
source: https://ibb.co/rmWZz2d

White House's commitment to export millions of Covid-19 vaccines overseas has created challenges to negotiate and work with regulatory authorities to deal with them as many countries seek US help to overcome vaccine shortages.

Since President Joe Biden announced this month that 80 million guns will be exported by the end of June, the White House will still be sending more volumes due to various problems from administration planning. Currently, infections are on the rise in countries from Haiti to Japan, fighting the organizational challenges and having only a small portion of the doses they need.

With the need for guns and half of adults fully vaccinated, the U.S. It has an excessive amount of use for vaccination conversations. About 70 million doses of Pfizer, Moderna and Johnson & Johnson vaccines are yet to be prescribed, according to data from the Centers for Disease Control and Prevention. But deciding where to go and taking them where they are needed is a herculean task, says a person familiar with the procedure.

The provincial government has been sending volumes as soon as they leave production plants at tens of thousands of commercial pharmacies, vaccination centers and public health clinics across the country. That means there is no central location where millions of prices can be stored and can be easily packed and loaded onto planes.

White House Covid-19 coordinator Andy Slavitt said on Wednesday that the U.S. It is trying to move to a "strong distribution system" so that the provincial government can keep a better track of prices and exports.

There is also the challenge of transporting tens of millions of volumes worldwide, ensuring adequate flights and ensuring that the volumes are properly stored and that the countries they receive have the infrastructure to refrigerate and distribute them, said the administration official. .

The official said management should be reviewed in the coming days to address some of the doses.

Another major potential problem is obtaining authorization for food and drug administration with the AstraZeneca vaccine. Of the 80 million doses promised so far, 60 million should have come from AstraZeneca - but authorities say they will not release those doses until the drug is cleared by U.S. regulators, even if it is approved for use in other countries.

The FDA review process has been delayed by detailed problems with AstraZeneca research, and it is unclear when the AstraZeneca vaccine will be available - or at least.

Then there is the balance in trying to figure out which countries should get the rating and how many partners are fighting the deficit. It is a challenge Biden could face when he meets world leaders next month at the G7 summit in the UK, his first major international event.

When Biden said the U.S. He will not use doses to protect the international community, but acknowledged that this action is an important tool in combating Chinese and Russian efforts to gain influence over their vaccines.

"There is a lot of talk about Russia and China that has an impact on the world with vaccines. We want to lead the world with our values, this shows our wisdom, ingenuity and basic morals of the American people," Bidid announced this month. "Just as in the Second World War the United States was a democracy, in the fight against the Covid-19 epidemic our country will be a global vaccine."

Following a recent meeting with the president of South Korea, in which about 3 percent of the population was completely vaccinated, Biden said the U.S. It will provide 500,000 doses of vaccine to members of the U.S. military. In the world.

Officials say little about its policy of determining which countries get the ratings and how many, without the broad intention of sending them where many lives could be saved.

"Those decisions are based on two things: science and public health, and equality - not other things," Slavitt said.

One of the countries most in need is Haiti: Vaccines have never been vaccinated, and while there are no definite statistics on how many people are infected, public health officials say the number of cases is rising.

The Haitian government has announced that it will receive 130,000 doses of AstraZeneca vaccine from the international aid group COVAX, a country that had previously rejected it; doses could arrive in June, according to the Pan American Health Organization.

But that is only the beginning of the 11 million people on earth. Public health workers say a single Johnson & Johnson vaccine will make a big difference in Haiti, where hiring people to get two AstraZeneca rifles could be a challenge.

Biden has given Jeffrey Zients, a financial coordinator at the White House, to lead these efforts. He also works with national security adviser Jake Sullivan and Gayle Smith, Covid-19's global response coordinator at the Department of State. U.S. staff members The Agency for International Development and the Department of Health and Human Services are also involved.

The White House said it was working with the World Health Organization and COVAX, which works to find drugs in low- and middle-income countries, to ensure that doses are evenly distributed.

The administration official acknowledged the challenges of the release, saying the commitment could be just the beginning.